Skip to main content
. 2024 Apr 8;26(4):euae043. doi: 10.1093/europace/euae043

Table 10.

Unanswered questions in AF ablation

Topic Questions
Basic/translational science
  • What are the mechanisms of AF?

  • What are the best preclinical models of AF for understanding human disease?

Risk factor modification
  • Treatment of which risk factors (i.e. OSA, obesity, hypertension, physical inactivity) improve outcome after AF ablation?

  • Does maintenance of risk factor modification reduce late AF recurrences?

  • Can pharmacologic prevention of remodelling/fibrosis improve long-term freedom from AF after ablation?

Patient selection—personalized management
  • Can machine learning and artificial intelligence improve patient selection and downstream clinical outcomes?

  • Can we develop a personalized approach to AF ablation based on risk factors, AF duration, and atrial substrate?

  • Do asymptomatic individuals benefit from catheter ablation, including reductions in cardiovascular adverse events?

Energy sources—ablation tools
  • What are the optimal settings for cryothermy and radiofrequency ablation in different LA regions?

  • What are the optimal PFA settings for AF ablation (delivery design, dose)?

  • Does PFA improve long-term outcomes when compared with radiofrequency or cryoballoon ablation?

  • Does PFA improve the safety and efficacy of additional substrate modification?

  • Are there unrecognized safety concerns if more extensive PFA leads to greater proportions of atrial myocardium being ablated?

  • Can combined pulsed field and thermal ablation modalities improve AF ablation efficacy and safety?

Ablation strategies
  • Can we prevent PV reconnection after PVI?

  • What is the optimal ablation approach of persistent AF?

  • Can ablation based upon computer simulations of the interactions between substrate and arrhythmia provide personalized ablation strategies and lesion sets that result in safer, more effective, and more efficient procedures?

  • Can we reproducibly map focal AF drivers and does ablation of these focal sources lead to improved outcomes?

  • Which patients benefit from hybrid ablation? Are outcomes and safety improved compared with catheter ablation?

Endpoints and outcomes after ablation
  • Can wearable technologies offer reliable monitoring of AF burden after AF ablation?

  • What is the optimal and most pragmatic efficacy endpoint for arrhythmia suppression after AF ablation?

AF, atrial fibrillation; LA, left atrial; OSA, obstructive sleep apnoea; PFA, pulsed field ablation; PV, pulmonary vein; PVI, PV isolation.